Physiological considerations in the design of particulate dosage forms for oral vaccine delivery

Advanced Drug Delivery Reviews

Volumn 34, Issue 2-3, 1998, Pages 123-133

  Yeh, Ping Yang ^a   Ellens, Harma ^a   Smith, Philip L ^a  

^a SmithKline Beecham UP1230 1250 S ^*  (United States)

Author keywords

Absorption; Enterocyte; Gut associated lymphoid tissue; Intestine; M cells; Particulates; Peptides; Peyer's patch; Proteins; Transport; Vaccine

Indexed keywords

ABSORPTION; CELLS; CONTROLLED DRUG DELIVERY; PARTICLES (PARTICULATE MATTER); PHYSIOLOGY; PROTEINS; TISSUE; TRANSPORT PROPERTIES; VACCINES;

ENTEROCYTE; GASTROINTESTINAL TRACT; GUT ASSOCIATED LYMPHOID TISSUE; ORAL VACCINE DELIVERY; PEPTIDES; PEYER PATCH;

DRUG DOSAGE;

CARRIER PROTEIN; ENZYME; LECTIN; LIGAND; PEPTIDE; PROTEIN; VACCINE;

CELL POPULATION; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG DOSAGE FORM; EPITHELIUM CELL; GASTROINTESTINAL ABSORPTION; GASTROINTESTINAL TRACT; HYDROPHOBICITY; INTESTINE LYMPHATIC TISSUE; LYMPHOCYTE; MUCUS; PEYER PATCH; PH; PHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

EID: 0032403490     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(98)00036-2     Document Type: Review

References (91)

1. Smith P.L., Wall D.A., Gochoco C., Wilson G. Oral absorption of peptides and proteins. Adv. Drug Del. Rev. 8:1992;253-290.
2. Leone-Bay A., Ho K.K., Agarwal R., Baughman R.A., Chaudhary K., DeMorin F., Genoble L., McInnes C., Lercara C., Milstein S., O'Toole D., Sarubbi D., Variano B., Paton D.R. 4-[4-[(2-Hydroxybenzoly)amino]phenyl]butyric acid as a novel oral delivery agent for recombinant human growth hormone. J. Med. Chem. 39:1996;2571-2578.
3. Schipper N.G.M., Olsson S., Hoogstraate J.A., deBoer A.G., Varum K.M., Artursson P. Chitosans as absorption enhancers for poorly absorable drugs 2: Mechanism of absorption enhancement. Pharm. Res. 14:1997;923-929.
4. Fix J.A. Oral controlled release technology for peptides: Status and future prospects. Pharm. Res. 13:1996;1760-1764.
5. Wang W. Oral protein drug delivery. J. Drug Targeting. 4:1996;195-232.
6. Nellans H.N. Paracellular intestinal transport: Modulation of absorption. Adv. Drug. Del. Rev. 7:1991;339-364.
7. Madara J.L. Maintenance of the macromolecular barrier at cell extrusion sites in intestinal epithelium: Physiological rearrangement of tight junctions. J. Membrane Biol. 116:1990;177-184.
8. Fasano A., Uzzau S. Modulation of intestinal tight junctions by Zonula occludens toxin permits enteral administration of insulin and other macromolecules in an animal model. J. Clin. Invest. 99:1997;1158-1164.
9. Turner J.R., Rill B.K., Carlson S.L., Carnes D., Kerner R., Mrsny R.J., Madara J.L. Physiological regulation of epithelial tight junctions is associated with myosin light-chain phosphorylation. Am. J. Physiol. 273:1997;C1378-C1385.
10. Lutz K.L., Siahaan T.J. Molecular structure of the apical junction complex and its contribution to the paracellular barrier. J. Pharm. Sci. 86:1997;977-984.
11. Mullin J.M., Marano C.W., Laughlin K.V., Nuciglio M., Stevenson B.R., Peralta Soler A. Different size limitation for increased transepithelial paracellular solute flux across phorbol ester and tumor necrosis factor-treated epithelial cell sheets. J. Cell Physiol. 171:1997;226-233.
12. Mullin J.M., Snock K.V. The effect of tumor necrosis factor on epithelial tight junctions and transepithelial permeability. Cancer Res. 50:1990;2172-2176.
13. Yeh P., Smith P.L., Ellens H. Effect of medium-chain glycerides on physiological properties of rabbit intestinal epithelium in vitro. Pharm. Res. 11:1994;1148-1154.
14. Muranishi S. Absorption enhancers. Crit. Rev. Ther. Drug Carrier Sys. 7:1990;1-33.
15. Swenson E.S., Curatolo W.J. Means to enhance penetration, 2. Intestinal permeability enhancement for proteins, peptides and other polar drugs; mechanisms and potential toxicity. Adv. Drug. Del. Rev. 8:1992;39-92.
16. Tzan C.J., Berg J.R., Lewis S.A. Modification of epithelial permeability by cationic polypeptides. Am. J. Physiol. 265:1993;C1637-C1647.
17. Tzan C.J., Berg J., Lewis S.A. Effect of protamine sulfate on the permeability properties of the mammalian urinary bladder. J. Memb. Biol. 133:1993;227-242.
18. Fasano A., Uzzau S., Fiore C., Margaretten K. The enterotoxic effect of Zonula occludens toxin on rabbit small intestine involves the paracellular pathway. Gastroenterology. 112:1997;839-846.
19. P.L. Smith, D.A. Wall, G. Wilson, Drug carriers for the oral administration and transport of peptide drugs across the gastrointestinal epithelium, in: A. Rolland (Ed.), Pharmaceutical Particulate Carriers: Therapeutic Applications, Marcel Dekker, Inc. New York, 1993, pp. 109-134.
20. Florence A.T. The oral absorption of micro- and nanoparticulates: neither exceptional nor unusual. Pharm. Res. 14:1997;259-262.
21. Lavelle E.C., Sharif S., Thomas N.W., Holland J., Davis S.S. The importance of gastrointestinal uptake of particles in the design of oral delivery systems. Adv. Drug Del. Rev. 18:1995;5-22.
22. O'Hagan D.T. Intestinal translocation of particles - implications for drug and antigen delivery. Adv. Drug. Del. Rev. 5:1990;265-285.
23. Kataoka K., Tabata J., Yamamoto M., Toyota T. The association of gap junctions with large particles in the crypt epithelium of the rat small intestine. Arch. Histol. Cytol. 52:1989;81-86.
24. Jani P.U., Florence A.T., McCarthy D.E. Further histological evidence of the gastrointestinal absorption of polystyrene nanospheres in the rat. Int. J. Pharm. 84:1992;245-252.
25. Aprahamian M., Michel C., Damge C. Transmucosal passage of polyalkylcyanoacrylate nanoparticles as a new drug carrier in the small intestine. Biol. Cell. 61:1987;69-76.
26. Madara J.L. The chameleon within: Improving antigen delivery. Science. 277:1997;910-911.
27. Mestecky J., Moldoveanu Z., Michalek S.M., Morrow C.D., Compans R.W., Schafer D.P., Russell M.W. Current options for vaccine delivery systems by mucosal routes. J. Control. Rel. 48:1997;243-257.
28. Florence A.T., Hillery A.M., Hussain N., Jani P.U. Factors affecting the oral uptake and translocation of polystyrene nanoparticles: Histological and analytical evidence. J. Drug Targeting. 3:1997;65-77.
29. Jani P., Halbert G.W., Langridge J., Florence A. Nanoparticle uptake by the rat gastrointestinal mucosa: Quantitation and particle size dependency. J. Pharm. Pharmacol. 42:1990;821-826.
30. Bockman D.E., Cooper M.D. Pinocytosis by epithelium associated with lymphoid follicles in the bursa of Fabricius, appendix, and Peyer's patches. An electron microscopic study. Am. J. Anat. 136:1973;455-478.
31. McClugage S., Low F.N., Zimny M. Porosity of the basement membrane overlying Peyer's patches in rats and monkeys. Gastroenterology. 91:1986;1128-1133.
32. Bhalla D.K., Murakami T., Owen R.L. Microcirculation of intestinal lymphoid follicles in rat Peyer's patches. Gastroenterology. 81:1981;481-491.
33. Yamaguchi K., Schoefl G.I. Blood vessels on the Peyer's patch in the mouse: I Topographic studies. Anat. Rec. 206:1983;391-401.
34. Allan C.H., Trier J.S. Structure and permeability differ in subepithelial villus and Peyer's patch follicle capillaries. Gastroenterology. 100:1991;1172-1179.
35. M.E. Le Fevre, D.D. Joel, Peyer's patch epithelium, an imperfect barrier, in: C.M. Schiller (Ed.), Intestinal Toxicology, Raven Press, New York, 1984, pp. 45-59.
36. Eldridge J.H., Hammond C.J., Meulbroek J.A., Staas J.K., Gilley R.M., Tice T.R. Controlled vaccine release in the gut-associated lymphoid tissues. I. Orally administrated biodegradable microspheres target the Peyer's patches. J. Control. Rel. 11:1990;205-214.
37. Jani P., Halbert G.W., Langridge J., Florence A.T. The uptake and translocation of latex nanospheres and microspheres after oral administration to rats. J. Pharm. Pharmacol. 41:1989;809-812.
38. Wells C.L., Maddaus M.A., Simmons R.L. Role of the macrophage in the translocation of intestinal bacteria. Arch. Surg. 122:1987;48-53.
39. Abe K., Ito T. A qualitative and quantitative morphologic study of Payer's patches of the mouse. Arch. Histol. Jap. 40:1977;407-420.
40. Smith M.W. Selective expression of brush border hydrolases by mouse Peyer's patch and jejunal villus enterocytes. J. Cell Physiol. 124:1985;219-225.
41. Kararli T.T. Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals. Biopharm. Drug Disp. 16:1995;351-380.
42. Kuhn E.M., Kaup F.J. Morphological characteristics of the ileal Peyer's patches in the Rhesus Macaque: a histological and ultrastructural study. Anat. Histol. Embryol. 25:1996;65-69.
43. Regoli M., Borghesi C., Bertelli E., Comparini L. Arrangement of the small intestine lymphatic network in the Peyer's patches of the mouse. A light and transmission electron microscopic study. Anat. Anz. 177:1995;229-235.
44. Nagata H., Miyairi M., Sekizuka E., Morishita T., Tatemichi M., Miura S., Tsuchiya M. In vivo visualization of lymphatic microvessels and lymphocyte migration through rat Peyer's patches. Gastroenterology. 106:1994;1548-1553.
45. Pappo J., Steger H.J., Owen R.L. Differential adherence of epithelium overlying gut-associated lymphoid tissue. Lab. Invest. 58:1988;692-697.
46. Smith M.W., Peacock M.A. M Cell distribution in follicle-associated epithelum of mouse Peyer's patch. Am. J. Anat. 159:1988;167-175.
47. Pappo J., Ermak T.H. Uptake and translocation of fluorescent latex particles by rabbit Peyer's patch follicle epithelium: a quantitative model for M cell uptake. Clin. Exp. Immunol. 76:1989;144-148.
48. Faulk W.P., McCormick J.N., Goodman J.R., Yoffey J.M., Fudenberg H.H. Peyer's patches: morphological studies. Cellular Immunol. 1:1971;500-520.
49. Cornes J.S. Number, size, and distribution of Peyer's patches in the human small intestine. Gut. 6:1965;225-229.
50. Pabst R., Geist M., Rothkotter H.J., Fritz F.J. Postnatal development and lymphocyte production of jejunal and ileal Peyer's patches in normal and gnotobiotic pigs. Immunology. 64:1988;539-544.
51. Gebert A., Rothkotter H.J., Pabst R. Cytokeratin 18 is an M-cell marker in porcine Peyer's patches. Cell Tissue Res. 276:1994;213-221.
52. Kuhn E.M., Kaup F.J. Morphological characteristics of the ileal Peyer's patches in the rhesus macaque: a histological and ultrastructural study. Anat. Histol. Embryol. 25:1996;65-69.
53. Owen R.L., Jones A.L. Epithelial cell specialization within human Peyer's patches: An ultrastructural study of intestinal lymphoid follicles. Gastroenterology. 66:1974;189-203.
54. Gebert A., Rothkotter H.-J., Pabst R. M Cells in Peyer's patches of the intestine. Int. Rev. Cytol. 167:1996;91-159.
55. Owen R.L., Ermak T.H. Structural specializations for antigen uptake and processing in the digestive tract. Springer Semin. Immunopathol. 12:1990;139-152.
56. Bye W.A., Allan C.H., Trier J.S. Structure, distribution, and origin of M cells in Peyer's patches of mouse ileum. Gastroenterology. 86:1984;789-801.
57. Neutra M.R., Pringault E., Kraehenbuhl J. Antigen sampling across epithelial barriers and induction of mucosal immune responses. Annu. Rev. Immunol. 14:1996;275-300.
58. M.R. Neutra, P.J. Giannasca, K.T. Giannasca, J.-P. Kraehenbuhl, M Cells and microbial pathogens, in: M.J. Blaser, P.D. Smith, J.I. Ravdin, H.B. Greenberg, R.L. Guerrant, (Eds.), Infections of the Gastrointestinal Tract, Raven Press, New York, 1995, pp. 163-178.
59. T.C. Savidge, M.W. Smith, Evidence that membranous (M) cell genesis is immunoregulated, in: J. Mestecky, (Ed.), Advances in Mucosal Immunology, Plenum, New York, 1995, pp. 239-241.
60. Kerneis S., Bogdanova A., Kraehenbuhl J., Pringault E. Conversion by Peyer's patch lymphocytes of human enterocytes into M cells that transport bacteria. Science. 277:1997;949-952.
61. Savidge T.C., Smith M.W., James P.S., Aldred P. Salmonella-induced M-cell formation in germ-free mouse Peyer's patch tissue. Am. J. Path. 139:1991;177-184.
62. Maury J., Nicoletti C., Guzzo-Chambraud I., Maroux S. The filamentous brush border glycocalyx, a mucin-like marker of enterocyte hyper-polarization. Eur. J. Biochem. 228:1995;323-331.
63. Semenza G. Anchoring and biosynthesis of stalked brush border membrane glycoproteins. Annu. Rev. Cell Biol. 2:1986;255-314.
64. Frey A., Giannasca K.T., Weltzin R., Giannasca P.J., Reggio H., Lencer W.I., Neutra M.R. Role of the glycocalyx in regulating access of microparticles to apical plasma membranes of intestinal epithelial cells: implications for microbial attachment and oral vaccine targeting. J. Exp. Med. 184:1996;1045-1059.
65. Hultgren S.J., Abraham S., Caparon M., Falk P., St. Geme III J.W., Normark S. Pilus and nonpilus bacterial adhesins: assembly and function in cell recognition. Cell. 73:1993;887-901.
66. Giannasca P.J., Giannasca K.T., Falk P., Gordon J.I., Neutra M.R. Regional differences in glycoconjugates of intestinal M cells in mice: potential targets for mucosal vaccines. Am. J. Physiol. 267:1994;G1108-G1121.
67. Sharma R., van Damme E.J.M., Penmans W.J., Sarsfield P., Schumacher U. Lectin binding reveals divergent carbohydrate expression in human and mouse Peyer's patches. Histochem. Cell Biol. 105:1996;459-465.
68. Clark M.A., Jepson M.A. Lectin binding defines and differentiates M-cells in mouse small intestine and caecum. Histochem. Cell Biol. 104:1995;161-168.
69. Clark M.A., Jepson M.A., Simmons N.L., Hirst B.H. Selective binding and transcytosis of Ulex europaeus 1 lectin by mouse Peyer's patch M-cells in vivo. Cell Tissue Res. 282:1995;455-461.
70. Clark M.A., Jepson M.A., Simmons N.L., Hirst B.H. Differential surface characteristics of M cells from mouse intestinal Peyer's and cacel patches. Histochem. J. 26:1994;271-280.
71. Jepson M.A., Simmons N.L., Hirst G.L., Hirst B.H. Identification of M cells and their distribution in rabbit intestinal Peyer's patches and appendix. Cell Tissue Res. 273:1993;127-136.
72. Jepson M.A., Mason C.M., Clark M.A., Simmons N.L., Hirst B.H. Variations in lectin binding properties of intestinal M cells. J. Drug Targeting. 3:1995;75-77.
73. Jepson M.A., Clark M.A., Simmons N.L., Hirst B.H. Epithelial M cells in the rabbit caecal lymphoid patch display distinctive surface characteristics. Histochemistry. 100:1993;441-447.
74. Clark M.A., Jepson M.A., Simmons N.L., Booth T.A., Hirst B.H. Differential expression of lectin-binding sites defines mouse intestinal M-cells. J. Histochem. Cytochem. 41:1993;1679-1687.
75. LeFevre M.E., Warren J.B., Joel D.D. Particles and macrophages in murine Peyer's patches. Exp. Cell Biol. 53:1985;121-129.
76. Hillery A.M., Florence A.T. The effect of adsorbed poloxamer 188 and 407 surfactants on the intestinal uptake of 60-nm polystyrene particles after oral administration in the rat. Int. J. Pharm. 132:1996;123-130.
77. Irache J.M., Durrer C., Duchene D., Ponchel G. Bioadhesion of lectin-latex conjugates to rat intestinal mucosa. Pharm. Res. 13:1996;1716-1719.
78. Hussain N., Jani P.U., Florence A.T. Enhanced oral uptake of tomato lectin-conjugated nanoparticles in the rat. Pharm. Res. 14:1997;613-618.
79. Pappo J., Ermak T.H., Steger H.J. Monoclonal antibody-directed targeting of fluorescent polystyrene microspheres to Peyer's patch M cells. Immunology. 73:1991;277-280.
80. Pappo J. Generation and characterization of monoclonal antibodies recognizing follicle epithelial M cells in rabbit gut-associated lymphoid tissues. Cellular Immunol. 120:1989;31-41.
81. Carr K., Hazzard R.A., Reid S., Hodges G.M. The effect of size on uptake of orally administrated latex microspheres in the small intestine and transport to mesenteric lymph nodes. Pharm. Res. 13:1996;1205-1209.
82. Eldridge J.H., Gilley R.M., Staas J.K., Moldoveanu Z., Meulbroek J.A., Tice T.R. Biodegradable microsphere: Vaccine delivery system for oral immunization. Curr. Top. Microbiol. Immunol. 146:1989;59-66.
83. Neutra M.R., Phillips T.L., Mayer E.L., Fishkind D.J. Transport of membrane-bound macromolecules by M cells in follicle-associated epithelium of rabbit Peyer's patch. Cell Tissue Res. 247:1987;537-546.
84. Owen R.L. Sequential uptake of horse radish peroxidase by lymphoid follicle epithelium of Peyer's patches in the normal unobstructed mouse intestine: an ultrastructural study. Gastroenterology. 72:1977;440-451.
85. Wolf J.L., Kaufmann R.S., Finberg R., Dambrauskas R., Fields B.N., Trier J.S. Determinants of reovirus interaction with the intestinal M cells and absorptive cells of murine intestine. Gastroenterology. 85:1983;291-300.
86. Wolf J.L., Rubin D.H., Finberg R., Kauffman R.S., Trier J.S., Fields B.N. Intestinal M cells: a pathway for entry of reovirus into the host. Sciences. 212:1981;471-472.
87. Trier J.S. Structure and function of intestinal M cells. Gastroenterol. Clinics North America. 20:1991;531-547.
88. Bennet K., Levine T., Ellis J.S., Peanasky R.J., Samloff I.M., Kay J., Chain B.M. Antigen processing for presentation by class II major histocompatibility complex requires cleavage by Cathepsin E. Eur. J. Immunol. 22:1992;1519-1524.
89. Finzi G., Cornaggia M., Capella C., Fiocca R., Bosi F., Solcia E. Cathepsin E in follicle associated epithelium of intestine and tonsils: localization to M cells and possible role in antigen processing. Histochemistry. 99:1993;201-211.
90. Allan C.H., Mendrick D.L., Trier J.S. Rat intestinal M cells contain acidic endosomal-lysosomal compartments and express class II major histocompatibility complex determinants. Gastroenterology. 104:1993;698-708.
91. Neutra M.R., Frey A., Kraehenbuhl J.-P. Epithelial M cells: Gateways for mucosal infection and immunization. Cell. 86:1996;345-348.